"PathName","N_Genes","DeltaFold","BestPvalue","Fold_Rv0827c_DMSO_noDrug","Pvalue_Rv0827c_DMSO_noDrug","Fold_Rv0827c_DMSO_RIF","Pvalue_Rv0827c_DMSO_RIF"
"Interferon Signaling",2,0.17688,"8.06e-02",0.09344,"2.64e-01",-0.08344,"8.06e-02"
"ESR-mediated signaling",2,0.17899,"3.00e-01",-0.09351,"3.00e-01",0.08548,"3.44e-01"
"Estrogen-dependent gene expression",2,0.17899,"3.00e-01",-0.09351,"3.00e-01",0.08548,"3.44e-01"
"Gene Silencing by RNA",2,0.17102,"2.46e-01",-0.0834,"7.01e-01",0.08762,"2.46e-01"
"MicroRNA (miRNA) biogenesis",2,0.17102,"2.46e-01",-0.0834,"7.01e-01",0.08762,"2.46e-01"
"LDL clearance",2,0.16955,"1.91e-01",0.06718,"1.00e+00",-0.10237,"1.91e-01"
"Plasma lipoprotein clearance",2,0.16955,"1.91e-01",0.06718,"1.00e+00",-0.10237,"1.91e-01"
"Formation of HIV elongation complex in the absence of HIV Tat",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Signaling by Receptor Tyrosine Kinases",2,0.17432,"4.79e-01",-0.08794,"5.24e-01",0.08638,"4.79e-01"
"Formation of HIV-1 elongation complex containing HIV-1 Tat",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Formation of RNA Pol II elongation complex",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Formation of TC-NER Pre-Incision Complex",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Formation of the Early Elongation Complex",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Formation of the HIV-1 Early Elongation Complex",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"HIV Transcription Elongation",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"HIV Transcription Initiation",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Late Phase of HIV Life Cycle",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"mRNA Capping",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"RNA Pol II CTD phosphorylation and interaction with CE",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"RNA Pol II CTD phosphorylation and interaction with CE during HIV infection",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Membrane Trafficking",3,0.15299,"1.89e-02",0.07282,"1.89e-02",-0.08018,"5.67e-02"
"RNA Polymerase II HIV Promoter Escape",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Dual incision in TC-NER",4,0.14931,"4.68e-02",-0.07598,"1.83e-01",0.07333,"4.68e-02"
"RNA Polymerase II Pre-transcription Events",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"RNA Polymerase II Promoter Escape",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"RNA Polymerase II Transcription Elongation",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Signaling by NOTCH",2,0.15697,"2.61e-01",0.08519,"4.62e-01",-0.07178,"2.61e-01"
"DNA Double-Strand Break Repair",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"RNA Polymerase II Transcription Initiation",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"HDR through Homologous Recombination (HRR)",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"RNA Polymerase II Transcription Initiation And Promoter Clearance",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Utilization of Ketone Bodies",2,0.13559,"2.22e-03",0.07832,"2.22e-03",-0.05727,"3.03e-01"
"Homology Directed Repair",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"Tat-mediated elongation of the HIV-1 transcript",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Translesion synthesis by POLK",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"TP53 Regulates Transcription of DNA Repair Genes",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"Translesion synthesis by REV1",2,0.13992,"1.68e-01",-0.07452,"4.91e-01",0.0654,"1.68e-01"
"Synthesis of glycosylphosphatidylinositol (GPI)",2,0.11462,"6.17e-02",0.04624,"1.00e+00",-0.06838,"6.17e-02"
"Transcription of the HIV genome",2,0.1587,"4.47e-01",-0.07745,"8.20e-01",0.08125,"4.47e-01"
"trans-Golgi Network Vesicle Budding",2,0.13769,"2.46e-01",0.0619,"2.46e-01",-0.07578,"2.52e-01"
"Cytosolic tRNA aminoacylation",2,0.12511,"3.27e-01",-0.04261,"1.00e+00",0.0825,"3.27e-01"
"Endogenous sterols",3,0.10285,"8.78e-02",0.06523,"8.78e-02",-0.03762,"1.00e+00"
"Vesicle-mediated transport",4,0.10636,"1.64e-01",0.05013,"1.64e-01",-0.05623,"2.66e-01"
"Gap-filling DNA repair synthesis and ligation in TC-NER",5,0.10678,"4.11e-01",-0.0575,"4.11e-01",0.04928,"5.19e-01"
"Nucleotide Excision Repair",5,0.10678,"4.11e-01",-0.0575,"4.11e-01",0.04928,"5.19e-01"
"Transcription-Coupled Nucleotide Excision Repair (TC-NER)",5,0.10678,"4.11e-01",-0.0575,"4.11e-01",0.04928,"5.19e-01"
"Amino acid transport across the plasma membrane",3,0.09825,"2.48e-01",0.04708,"3.82e-01",-0.05117,"2.48e-01"
"Chromosome Maintenance",3,0.11225,"5.40e-01",-0.06417,"5.40e-01",0.04808,"1.00e+00"
"Telomere Maintenance",3,0.11225,"5.40e-01",-0.06417,"5.40e-01",0.04808,"1.00e+00"
"Glycerophospholipid biosynthesis",9,0.08691,"3.88e-03",0.04113,"3.88e-03",-0.04579,"8.13e-02"
"Dual Incision in GG-NER",3,0.09093,"3.15e-01",-0.04495,"1.00e+00",0.04599,"3.15e-01"
"Keratan sulfate degradation",2,0.08948,"3.40e-01",0.02328,"1.00e+00",-0.0662,"3.40e-01"
"Keratan sulfate/keratin metabolism",2,0.08948,"3.40e-01",0.02328,"1.00e+00",-0.0662,"3.40e-01"
"Plasma lipoprotein assembly, remodeling, and clearance",5,0.1006,"5.79e-01",0.04444,"1.00e+00",-0.05616,"5.79e-01"
"Cytochrome P450 - arranged by substrate type",5,0.08746,"4.33e-01",0.03975,"1.00e+00",-0.04771,"4.33e-01"
"Estrogen biosynthesis",2,0.11362,"1.00e+00",0.05567,"1.00e+00",-0.05795,"1.00e+00"
"Translesion Synthesis by POLH",2,0.08162,"1.42e-02",-0.04743,"9.65e-01",0.0342,"1.42e-02"
"Cholesterol biosynthesis",5,0.08185,"1.75e-01",0.03764,"1.00e+00",-0.04421,"1.75e-01"
"Regulation of insulin secretion",2,0.09239,"7.06e-01",0.03854,"1.00e+00",-0.05385,"7.06e-01"
"Post-translational modification: synthesis of GPI-anchored proteins",3,0.07807,"1.10e-01",0.02697,"1.00e+00",-0.05109,"1.10e-01"
"DNA Damage Bypass",4,0.0855,"5.76e-01",-0.06081,"5.76e-01",0.02469,"1.00e+00"
"Metabolism of fat-soluble vitamins",2,0.09781,"1.00e+00",0.04891,"1.00e+00",-0.0489,"1.00e+00"
"Pyrophosphate hydrolysis",2,0.09042,"8.46e-01",-0.02338,"1.00e+00",0.06705,"8.46e-01"
"Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template",4,0.0855,"5.76e-01",-0.06081,"5.76e-01",0.02469,"1.00e+00"
"Beta oxidation of myristoyl-CoA to lauroyl-CoA",3,0.0754,"8.28e-02",0.03358,"3.34e-01",-0.04182,"8.28e-02"
"Aspirin ADME",2,0.09194,"1.00e+00",0.02708,"1.00e+00",-0.06485,"1.00e+00"
"Phospholipid metabolism",11,0.07366,"6.88e-02",0.03068,"1.94e-01",-0.04298,"6.88e-02"
"Synthesis of bile acids and bile salts via 24-hydroxycholesterol",2,0.08501,"6.41e-01",0.02817,"1.00e+00",-0.05684,"6.41e-01"
"Synthesis of UDP-N-acetyl-glucosamine",2,0.07267,"9.07e-02",0.03057,"9.07e-02",-0.0421,"3.86e-01"
"Termination of translesion DNA synthesis",3,0.08481,"8.01e-01",-0.06275,"8.01e-01",0.02206,"1.00e+00"
"Synthesis of very long-chain fatty acyl-CoAs",4,0.07545,"4.23e-01",0.03638,"5.30e-01",-0.03907,"4.23e-01"
"Translesion synthesis by POLI",3,0.08481,"8.01e-01",-0.06275,"8.01e-01",0.02206,"1.00e+00"
"Molybdenum cofactor biosynthesis",5,0.08568,"1.00e+00",0.05386,"1.00e+00",-0.03182,"1.00e+00"
"Aspartate and asparagine metabolism",2,0.07909,"5.77e-01",-0.03801,"5.77e-01",0.04108,"6.91e-01"
"rRNA modification in the mitochondrion",2,0.06654,"1.31e-02",-0.04309,"1.31e-02",0.02345,"1.00e+00"
"HIV Life Cycle",3,0.08468,"1.00e+00",-0.04616,"1.00e+00",0.03852,"1.00e+00"
"Diseases of signal transduction by growth factor receptors and second messengers",7,0.06958,"4.24e-01",-0.04034,"4.24e-01",0.02923,"9.49e-01"
"Activation of gene expression by SREBF (SREBP)",3,0.08149,"1.00e+00",-0.04854,"1.00e+00",0.03295,"1.00e+00"
"Regulation of cholesterol biosynthesis by SREBP (SREBF)",3,0.08149,"1.00e+00",-0.04854,"1.00e+00",0.03295,"1.00e+00"
"DNA Damage Reversal",2,0.07966,"1.00e+00",-0.02587,"1.00e+00",0.05378,"1.00e+00"
"HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand",2,0.06854,"4.53e-01",-0.03151,"4.53e-01",0.03703,"6.60e-01"
"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",3,0.07594,"1.00e+00",0.02104,"1.00e+00",-0.0549,"1.00e+00"
"Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA",5,0.0617,"1.12e-01",0.02868,"1.12e-01",-0.03302,"2.46e-01"
"Interleukin-12 family signaling",3,0.07594,"1.00e+00",0.02104,"1.00e+00",-0.0549,"1.00e+00"
"Glycosaminoglycan metabolism",3,0.06761,"4.59e-01",0.01757,"1.00e+00",-0.05004,"4.59e-01"
"Interleukin-12 signaling",3,0.07594,"1.00e+00",0.02104,"1.00e+00",-0.0549,"1.00e+00"
"Mucopolysaccharidoses",3,0.06761,"4.59e-01",0.01757,"1.00e+00",-0.05004,"4.59e-01"
"Formation of xylulose-5-phosphate",2,0.07162,"8.56e-01",0.03747,"1.00e+00",-0.03415,"8.56e-01"
"Vitamin B5 (pantothenate) metabolism",4,0.07181,"9.42e-01",-0.03836,"9.42e-01",0.03345,"1.00e+00"
"Synthesis, secretion, and deacylation of Ghrelin",2,0.07345,"1.00e+00",0.02785,"1.00e+00",-0.04559,"1.00e+00"
"Cytokine Signaling in Immune system",8,0.07071,"9.72e-01",0.03017,"9.72e-01",-0.04054,"1.00e+00"
"Gap-filling DNA repair synthesis and ligation in GG-NER",3,0.07217,"1.00e+00",-0.04421,"1.00e+00",0.02796,"1.00e+00"
"The canonical retinoid cycle in rods (twilight vision)",4,0.06235,"5.17e-01",0.05082,"5.17e-01",-0.01153,"1.00e+00"
"Transport of inorganic cations/anions and amino acids/oligopeptides",8,0.06826,"9.50e-01",0.03727,"9.50e-01",-0.031,"1.00e+00"
"Galactose catabolism",2,0.07042,"1.00e+00",0.0436,"1.00e+00",-0.02682,"1.00e+00"
"Synthesis of PA",4,0.05502,"9.53e-02",0.03036,"9.53e-02",-0.02466,"3.44e-01"
"Sensory Perception",6,0.06263,"8.61e-01",0.04195,"8.61e-01",-0.02068,"1.00e+00"
"Visual phototransduction",6,0.06263,"8.61e-01",0.04195,"8.61e-01",-0.02068,"1.00e+00"
"Acyl chain remodeling of CL",2,0.05906,"5.49e-01",0.02481,"1.00e+00",-0.03424,"5.49e-01"
"Diseases of carbohydrate metabolism",6,0.05679,"3.13e-01",0.02226,"1.00e+00",-0.03453,"3.13e-01"
"Antimicrobial peptides",3,0.05711,"3.68e-01",-0.04515,"3.68e-01",0.01196,"1.00e+00"
"Beta oxidation of palmitoyl-CoA to myristoyl-CoA",2,0.05906,"5.49e-01",0.02481,"1.00e+00",-0.03424,"5.49e-01"
"Glycogen synthesis",2,0.05864,"4.82e-01",0.02483,"4.82e-01",-0.03381,"8.70e-01"
"rRNA processing in the mitochondrion",3,0.05974,"6.86e-01",-0.0278,"8.10e-01",0.03194,"6.86e-01"
"Alpha-oxidation of phytanate",4,0.06338,"1.00e+00",0.02325,"1.00e+00",-0.04013,"1.00e+00"
"Potential therapeutics for SARS",3,0.05313,"1.53e-01",-0.02924,"1.53e-01",0.02389,"6.87e-01"
"Biosynthesis of DHA-derived SPMs",2,0.06249,"1.00e+00",0.00621,"1.00e+00",-0.05628,"1.00e+00"
"Biosynthesis of maresins",2,0.06249,"1.00e+00",0.00621,"1.00e+00",-0.05628,"1.00e+00"
"Metabolism of steroid hormones",5,0.05998,"9.87e-01",0.03279,"9.87e-01",-0.0272,"1.00e+00"
"Biosynthesis of specialized proresolving mediators (SPMs)",2,0.06249,"1.00e+00",0.00621,"1.00e+00",-0.05628,"1.00e+00"
"Protein repair",3,0.05938,"1.00e+00",0.04003,"1.00e+00",-0.01935,"1.00e+00"
"DNA Repair",17,0.05095,"1.48e-01",-0.03192,"1.48e-01",0.01903,"1.00e+00"
"Protein methylation",4,0.05632,"8.06e-01",-0.04106,"8.06e-01",0.01526,"1.00e+00"
"Binding and Uptake of Ligands by Scavenger Receptors",2,0.05806,"1.00e+00",0.02761,"1.00e+00",-0.03045,"1.00e+00"
"NFE2L2 regulates pentose phosphate pathway genes",3,0.05396,"7.38e-01",0.02051,"1.00e+00",-0.03345,"7.38e-01"
"Scavenging by Class A Receptors",2,0.05806,"1.00e+00",0.02761,"1.00e+00",-0.03045,"1.00e+00"
"Cardiac conduction",2,0.05796,"1.00e+00",0.02827,"1.00e+00",-0.02969,"1.00e+00"
"Ion influx/efflux at host-pathogen interface",2,0.05423,"8.26e-01",-0.04446,"8.26e-01",0.00977,"1.00e+00"
"Metabolism of Angiotensinogen to Angiotensins",2,0.05796,"1.00e+00",0.02827,"1.00e+00",-0.02969,"1.00e+00"
"Arachidonate production from DAG",2,0.05338,"8.23e-01",0.04409,"8.23e-01",-0.0093,"1.00e+00"
"Physiological factors",2,0.05796,"1.00e+00",0.02827,"1.00e+00",-0.02969,"1.00e+00"
"Effects of PIP2 hydrolysis",2,0.05338,"8.23e-01",0.04409,"8.23e-01",-0.0093,"1.00e+00"
"Mitochondrial calcium ion transport",3,0.04995,"3.48e-01",-0.02643,"3.48e-01",0.02351,"6.16e-01"
"G alpha (q) signalling events",2,0.05338,"8.23e-01",0.04409,"8.23e-01",-0.0093,"1.00e+00"
"Processing of SMDT1",3,0.04995,"3.48e-01",-0.02643,"3.48e-01",0.02351,"6.16e-01"
"Sulfide oxidation to sulfate",3,0.05485,"1.00e+00",0.0467,"1.00e+00",-0.00815,"1.00e+00"
"Fatty acid metabolism",34,0.04492,"1.88e-02",0.01838,"7.61e-01",-0.02653,"1.88e-02"
"Ub-specific processing proteases",2,0.05077,"6.44e-01",0.02259,"6.44e-01",-0.02818,"1.00e+00"
"Glycogen breakdown (glycogenolysis)",2,0.05133,"9.37e-01",-0.03601,"9.37e-01",0.01531,"1.00e+00"
"Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA",4,0.0501,"7.02e-01",0.02307,"7.02e-01",-0.02703,"1.00e+00"
"Beta oxidation of octanoyl-CoA to hexanoyl-CoA",4,0.0501,"7.02e-01",0.02307,"7.02e-01",-0.02703,"1.00e+00"
"HIV Infection",4,0.05286,"1.00e+00",-0.02996,"1.00e+00",0.0229,"1.00e+00"
"Global Genome Nucleotide Excision Repair (GG-NER)",4,0.05236,"1.00e+00",-0.0296,"1.00e+00",0.02276,"1.00e+00"
"alpha-linolenic (omega3) and linoleic (omega6) acid metabolism",5,0.05195,"1.00e+00",0.02569,"1.00e+00",-0.02626,"1.00e+00"
"alpha-linolenic acid (ALA) metabolism",5,0.05195,"1.00e+00",0.02569,"1.00e+00",-0.02626,"1.00e+00"
"Influenza Infection",9,0.05121,"1.00e+00",-0.03136,"1.00e+00",0.01985,"1.00e+00"
"Cellular response to mitochondrial stress",2,0.04737,"6.57e-01",-0.02853,"6.57e-01",0.01885,"9.65e-01"
"Glutathione conjugation",4,0.04817,"8.62e-01",-0.03468,"8.62e-01",0.01349,"1.00e+00"
"Influenza Viral RNA Transcription and Replication",9,0.05121,"1.00e+00",-0.03136,"1.00e+00",0.01985,"1.00e+00"
"Glutathione synthesis and recycling",4,0.04817,"8.62e-01",-0.03468,"8.62e-01",0.01349,"1.00e+00"
"SLC transporter disorders",6,0.05108,"1.00e+00",0.02478,"1.00e+00",-0.0263,"1.00e+00"
"Metabolism of lipids",67,0.04118,"1.55e-04",0.01458,"1.00e+00",-0.0266,"1.55e-04"
"Cell recruitment (pro-inflammatory response)",2,0.0447,"5.91e-01",-0.01857,"1.00e+00",0.02613,"5.91e-01"
"Inflammasomes",2,0.0447,"5.91e-01",-0.01857,"1.00e+00",0.02613,"5.91e-01"
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",2,0.0447,"5.91e-01",-0.01857,"1.00e+00",0.02613,"5.91e-01"
"Transcriptional Regulation by TP53",12,0.04607,"9.69e-01",-0.02863,"9.69e-01",0.01744,"1.00e+00"
"Purinergic signaling in leishmaniasis infection",2,0.0447,"5.91e-01",-0.01857,"1.00e+00",0.02613,"5.91e-01"
"The NLRP3 inflammasome",2,0.0447,"5.91e-01",-0.01857,"1.00e+00",0.02613,"5.91e-01"
"Sphingolipid catabolism",2,0.04048,"6.26e-02",-0.02042,"1.00e+00",0.02006,"6.26e-02"
"Ketone body metabolism",3,0.04802,"1.00e+00",0.02268,"1.00e+00",-0.02534,"1.00e+00"
"Plasma lipoprotein remodeling",2,0.04798,"1.00e+00",0.04056,"1.00e+00",-0.00743,"1.00e+00"
"NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",2,0.04755,"1.00e+00",0.01019,"1.00e+00",-0.03736,"1.00e+00"
"Epigenetic regulation of gene expression",2,0.04683,"1.00e+00",0.03087,"1.00e+00",-0.01596,"1.00e+00"
"Azathioprine ADME",5,0.04571,"1.00e+00",-0.00402,"1.00e+00",0.04169,"1.00e+00"
"Neurotransmitter release cycle",3,0.04565,"1.00e+00",0.02261,"1.00e+00",-0.02304,"1.00e+00"
"Phase I - Functionalization of compounds",14,0.04506,"1.00e+00",0.02327,"1.00e+00",-0.02179,"1.00e+00"
"Diseases of DNA repair",4,0.04241,"7.52e-01",-0.02752,"7.52e-01",0.01489,"1.00e+00"
"Unfolded Protein Response (UPR)",2,0.04163,"7.28e-01",-0.0273,"7.28e-01",0.01433,"1.00e+00"
"Sphingolipid metabolism",7,0.04124,"6.25e-01",-0.03143,"6.25e-01",0.00982,"1.00e+00"
"mitochondrial fatty acid beta-oxidation of saturated fatty acids",6,0.04312,"9.14e-01",0.01944,"9.14e-01",-0.02368,"9.45e-01"
"Glycosphingolipid metabolism",5,0.04155,"7.88e-01",-0.03583,"7.88e-01",0.00572,"1.00e+00"
"Ubiquinol biosynthesis",3,0.04433,"1.00e+00",-0.01783,"1.00e+00",0.0265,"1.00e+00"
"SLC-mediated transmembrane transport",14,0.04421,"1.00e+00",0.02091,"1.00e+00",-0.0233,"1.00e+00"
"Fatty acyl-CoA biosynthesis",8,0.04414,"1.00e+00",0.01527,"1.00e+00",-0.02886,"1.00e+00"
"Muscle contraction",4,0.04411,"1.00e+00",0.0166,"1.00e+00",-0.02751,"1.00e+00"
"Transmission across Chemical Synapses",7,0.04382,"1.00e+00",0.01489,"1.00e+00",-0.02893,"1.00e+00"
"Mitochondrial protein import",7,0.04257,"1.00e+00",0.00857,"1.00e+00",-0.03401,"1.00e+00"
"Signaling by Nuclear Receptors",13,0.0413,"1.00e+00",-0.0296,"1.00e+00",0.0117,"1.00e+00"
"NR1H2 and NR1H3-mediated signaling",4,0.04117,"1.00e+00",-0.02697,"1.00e+00",0.0142,"1.00e+00"
"Dopamine clearance from the synaptic cleft",2,0.04055,"1.00e+00",-0.0268,"1.00e+00",0.01375,"1.00e+00"
"Enzymatic degradation of dopamine by COMT",2,0.04055,"1.00e+00",-0.0268,"1.00e+00",0.01375,"1.00e+00"
"Sulfur amino acid metabolism",11,0.04044,"1.00e+00",0.02609,"1.00e+00",-0.01436,"1.00e+00"
"Ion channel transport",4,0.04015,"1.00e+00",0.017,"1.00e+00",-0.02315,"1.00e+00"
"Peroxisomal lipid metabolism",11,0.03987,"1.00e+00",0.01619,"1.00e+00",-0.02368,"1.00e+00"
"Disorders of transmembrane transporters",11,0.0395,"1.00e+00",0.01376,"1.00e+00",-0.02573,"1.00e+00"
"Degradation of cysteine and homocysteine",6,0.03937,"1.00e+00",0.03844,"1.00e+00",-0.00092,"1.00e+00"
"Heparan sulfate/heparin (HS-GAG) metabolism",2,0.03857,"1.00e+00",0.00103,"1.00e+00",-0.03753,"1.00e+00"
"HS-GAG degradation",2,0.03857,"1.00e+00",0.00103,"1.00e+00",-0.03753,"1.00e+00"
"Metabolism of steroids",16,0.03846,"1.00e+00",0.01634,"1.00e+00",-0.02212,"1.00e+00"
"Diseases associated with visual transduction",3,0.03821,"1.00e+00",0.03511,"1.00e+00",-0.0031,"1.00e+00"
"Diseases of the neuronal system",3,0.03821,"1.00e+00",0.03511,"1.00e+00",-0.0031,"1.00e+00"
"Retinoid cycle disease events",3,0.03821,"1.00e+00",0.03511,"1.00e+00",-0.0031,"1.00e+00"
"Triglyceride catabolism",2,0.03793,"1.00e+00",0.02293,"1.00e+00",-0.01499,"1.00e+00"
"PPARA activates gene expression",2,0.0337,"6.63e-01",-0.00251,"1.00e+00",-0.06992,"6.63e-01"
"Sialic acid metabolism",3,0.03708,"1.00e+00",0.01192,"1.00e+00",-0.02516,"1.00e+00"
"Regulation of lipid metabolism by PPARalpha",2,0.0337,"6.63e-01",-0.00251,"1.00e+00",-0.06992,"6.63e-01"
"RHO GTPase cycle",9,0.03686,"1.00e+00",0.01849,"1.00e+00",-0.01837,"1.00e+00"
"Signaling by Rho GTPases",9,0.03686,"1.00e+00",0.01849,"1.00e+00",-0.01837,"1.00e+00"
"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",9,0.03686,"1.00e+00",0.01849,"1.00e+00",-0.01837,"1.00e+00"
"Purine ribonucleoside monophosphate biosynthesis",9,0.03263,"7.94e-01",-0.00917,"1.00e+00",0.02346,"7.94e-01"
"Pyrimidine catabolism",2,0.03647,"1.00e+00",-0.0276,"1.00e+00",0.00887,"1.00e+00"
"Platelet activation, signaling and aggregation",6,0.03646,"1.00e+00",0.02156,"1.00e+00",-0.0149,"1.00e+00"
"tRNA processing in the mitochondrion",2,0.03636,"1.00e+00",-0.01249,"1.00e+00",0.02387,"1.00e+00"
"Mitochondrial Fatty Acid Beta-Oxidation",14,0.03236,"7.99e-01",0.01269,"1.00e+00",-0.01967,"7.99e-01"
"GPCR downstream signalling",3,0.03598,"1.00e+00",0.02353,"1.00e+00",-0.01244,"1.00e+00"
"Signaling by GPCR",3,0.03598,"1.00e+00",0.02353,"1.00e+00",-0.01244,"1.00e+00"
"Neurotransmitter clearance",4,0.03589,"1.00e+00",0.01115,"1.00e+00",-0.02475,"1.00e+00"
"Protein localization",27,0.03086,"5.70e-01",0.00852,"1.00e+00",-0.02234,"5.70e-01"
"Detoxification of Reactive Oxygen Species",7,0.03559,"1.00e+00",0.02151,"1.00e+00",-0.01408,"1.00e+00"
"Triglyceride biosynthesis",2,0.03531,"1.00e+00",-0.01456,"1.00e+00",0.02075,"1.00e+00"
"Signaling by Interleukins",6,0.03531,"1.00e+00",0.00908,"1.00e+00",-0.02624,"1.00e+00"
"POLB-Dependent Long Patch Base Excision Repair",2,0.03529,"1.00e+00",0.01356,"1.00e+00",-0.02173,"1.00e+00"
"ChREBP activates metabolic gene expression",3,0.03525,"1.00e+00",-0.01828,"1.00e+00",0.01697,"1.00e+00"
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",4,0.03028,"7.11e-01",-0.01718,"7.11e-01",0.0131,"1.00e+00"
"Mitochondrial translation termination",28,0.03489,"1.00e+00",-0.0197,"1.00e+00",0.01519,"1.00e+00"
"Glycogen storage diseases",2,0.03463,"1.00e+00",0.01898,"1.00e+00",-0.01565,"1.00e+00"
"Regulation of ornithine decarboxylase (ODC)",2,0.02899,"3.65e-01",0.0126,"1.00e+00",-0.01639,"3.65e-01"
"Coenzyme A biosynthesis",2,0.03404,"1.00e+00",-0.01143,"1.00e+00",0.02262,"1.00e+00"
"Pyrimidine salvage",4,0.03395,"1.00e+00",0.0149,"1.00e+00",-0.01905,"1.00e+00"
"rRNA modification in the nucleus and cytosol",4,0.03325,"1.00e+00",-0.02678,"1.00e+00",0.00647,"1.00e+00"
"Leishmania infection",4,0.03258,"1.00e+00",-0.01913,"1.00e+00",0.01345,"1.00e+00"
"Parasitic Infection Pathways",4,0.03258,"1.00e+00",-0.01913,"1.00e+00",0.01345,"1.00e+00"
"Maternal to zygotic transition (MZT)",3,0.03228,"1.00e+00",-0.00898,"1.00e+00",0.0233,"1.00e+00"
"Serine biosynthesis",4,0.03225,"1.00e+00",0.01553,"1.00e+00",-0.01673,"1.00e+00"
"Metabolism of cofactors",6,0.03219,"1.00e+00",-0.00839,"1.00e+00",0.02379,"1.00e+00"
"M-decay: degradation of maternal mRNAs by maternally stored factors",2,0.032,"1.00e+00",-0.01315,"1.00e+00",0.01884,"1.00e+00"
"Cell Cycle",10,0.03141,"1.00e+00",-0.01577,"1.00e+00",0.01564,"1.00e+00"
"Diseases of Base Excision Repair",3,0.03133,"1.00e+00",-0.02341,"1.00e+00",0.00792,"1.00e+00"
"Transport of small molecules",38,0.03125,"1.00e+00",0.01178,"1.00e+00",-0.01947,"1.00e+00"
"Mitochondrial translation elongation",27,0.03121,"1.00e+00",-0.01857,"1.00e+00",0.01264,"1.00e+00"
"Biological oxidations",26,0.03041,"1.00e+00",0.00805,"1.00e+00",-0.02236,"1.00e+00"
"Beta oxidation of hexanoyl-CoA to butanoyl-CoA",5,0.03013,"1.00e+00",0.0131,"1.00e+00",-0.01703,"1.00e+00"
"Synthesis of substrates in N-glycan biosythesis",10,0.03007,"1.00e+00",0.0082,"1.00e+00",-0.02187,"1.00e+00"
"Nuclear events mediated by NFE2L2",9,0.02995,"1.00e+00",0.00786,"1.00e+00",-0.02209,"1.00e+00"
"Peroxisomal protein import",19,0.0298,"1.00e+00",0.00958,"1.00e+00",-0.02022,"1.00e+00"
"Heme biosynthesis",7,0.02973,"1.00e+00",-0.01947,"1.00e+00",0.01026,"1.00e+00"
"Metabolism of porphyrins",7,0.02973,"1.00e+00",-0.01947,"1.00e+00",0.01026,"1.00e+00"
"Bile acid and bile salt metabolism",5,0.02967,"1.00e+00",0.00775,"1.00e+00",-0.02191,"1.00e+00"
"Synthesis of bile acids and bile salts",5,0.02967,"1.00e+00",0.00775,"1.00e+00",-0.02191,"1.00e+00"
"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",5,0.02967,"1.00e+00",0.00775,"1.00e+00",-0.02191,"1.00e+00"
"Mitochondrial iron-sulfur cluster biogenesis",3,0.02949,"1.00e+00",0.02082,"1.00e+00",-0.00867,"1.00e+00"
"Ion transport by P-type ATPases",3,0.02934,"1.00e+00",0.01026,"1.00e+00",-0.01908,"1.00e+00"
"Interleukin-4 and Interleukin-13 signaling",2,0.02928,"1.00e+00",-0.01364,"1.00e+00",0.01564,"1.00e+00"
"mitochondrial fatty acid beta-oxidation of unsaturated fatty acids",4,0.02909,"1.00e+00",0.0086,"1.00e+00",-0.02049,"1.00e+00"
"Mitochondrial protein degradation",30,0.02409,"8.77e-01",0.00908,"1.00e+00",-0.015,"8.77e-01"
"Platelet degranulation",4,0.02799,"1.00e+00",0.0103,"1.00e+00",-0.0177,"1.00e+00"
"Response to elevated platelet cytosolic Ca2+",4,0.02799,"1.00e+00",0.0103,"1.00e+00",-0.0177,"1.00e+00"
"tRNA processing in the nucleus",2,0.0278,"1.00e+00",-0.01994,"1.00e+00",0.00786,"1.00e+00"
"Displacement of DNA glycosylase by APEX1",5,0.02757,"1.00e+00",-0.01173,"1.00e+00",0.01584,"1.00e+00"
"Signaling by ALK fusions and activated point mutants",2,0.02734,"1.00e+00",-0.02118,"1.00e+00",0.00616,"1.00e+00"
"Signaling by ALK in cancer",2,0.02734,"1.00e+00",-0.02118,"1.00e+00",0.00616,"1.00e+00"
"Serotonin clearance from the synaptic cleft",2,0.02698,"1.00e+00",0.00801,"1.00e+00",-0.01897,"1.00e+00"
"Plasmalogen biosynthesis",3,0.02695,"1.00e+00",0.00648,"1.00e+00",-0.02046,"1.00e+00"
"Wax and plasmalogen biosynthesis",3,0.02695,"1.00e+00",0.00648,"1.00e+00",-0.02046,"1.00e+00"
"Nucleotide biosynthesis",12,0.02661,"1.00e+00",-0.00827,"1.00e+00",0.01834,"1.00e+00"
"Citric acid cycle (TCA cycle)",14,0.02254,"9.71e-01",0.00069,"1.00e+00",-0.02185,"9.71e-01"
"Mitochondrial translation initiation",27,0.02624,"1.00e+00",-0.01582,"1.00e+00",0.01042,"1.00e+00"
"Neuronal System",9,0.02622,"1.00e+00",0.00752,"1.00e+00",-0.01871,"1.00e+00"
"Viral Infection Pathways",22,0.02608,"1.00e+00",-0.02014,"1.00e+00",0.00593,"1.00e+00"
"Nucleotide salvage",8,0.02595,"1.00e+00",0.01467,"1.00e+00",-0.01128,"1.00e+00"
"Urea cycle",4,0.02583,"1.00e+00",0.0093,"1.00e+00",-0.01653,"1.00e+00"
"ABC transporter disorders",5,0.02559,"1.00e+00",0.00054,"1.00e+00",-0.02505,"1.00e+00"
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",11,0.02555,"1.00e+00",0.00822,"1.00e+00",-0.01733,"1.00e+00"
"Complex I biogenesis",10,0.02521,"1.00e+00",0.01953,"1.00e+00",-0.00568,"1.00e+00"
"Metal ion SLC transporters",2,0.02514,"1.00e+00",-0.05126,"1.00e+00",-0.00097,"1.00e+00"
"Abacavir transmembrane transport",2,0.02504,"1.00e+00",-0.00973,"1.00e+00",-0.0598,"1.00e+00"
"Hemostasis",8,0.02479,"1.00e+00",0.01301,"1.00e+00",-0.01178,"1.00e+00"
"Mitochondrial translation",33,0.02426,"1.00e+00",-0.01653,"1.00e+00",0.00772,"1.00e+00"
"Cleavage of the damaged purine",3,0.02405,"1.00e+00",-0.023,"1.00e+00",0.00105,"1.00e+00"
"Depurination",3,0.02405,"1.00e+00",-0.023,"1.00e+00",0.00105,"1.00e+00"
"Recognition and association of DNA glycosylase with site containing an affected purine",3,0.02405,"1.00e+00",-0.023,"1.00e+00",0.00105,"1.00e+00"
"Anti-inflammatory response favouring Leishmania parasite infection",2,0.02045,"9.72e-01",-0.01969,"9.72e-01",0.00076,"1.00e+00"
"RHOH GTPase cycle",3,0.02398,"1.00e+00",0.00806,"1.00e+00",-0.01592,"1.00e+00"
"Leishmania parasite growth and survival",2,0.02045,"9.72e-01",-0.01969,"9.72e-01",0.00076,"1.00e+00"
"Propionyl-CoA catabolism",3,0.02388,"1.00e+00",0.00707,"1.00e+00",-0.01681,"1.00e+00"
"Infectious disease",26,0.02384,"1.00e+00",-0.01789,"1.00e+00",0.00595,"1.00e+00"
"Integration of energy metabolism",6,0.02363,"1.00e+00",0.00992,"1.00e+00",-0.01371,"1.00e+00"
"Atorvastatin ADME",3,0.02306,"1.00e+00",-0.0127,"1.00e+00",-0.05881,"1.00e+00"
"Prednisone ADME",3,0.02306,"1.00e+00",-0.0127,"1.00e+00",-0.05881,"1.00e+00"
"Fructose metabolism",2,0.02289,"1.00e+00",0.01194,"1.00e+00",-0.01095,"1.00e+00"
"rRNA processing",15,0.02265,"1.00e+00",-0.01617,"1.00e+00",0.00648,"1.00e+00"
"Cobalamin (Cbl) metabolism",3,0.02253,"1.00e+00",0.00021,"1.00e+00",-0.02232,"1.00e+00"
"Vitamin B6 activation to pyridoxal phosphate",3,0.02252,"1.00e+00",-0.01045,"1.00e+00",0.01207,"1.00e+00"
"Defective CFTR causes cystic fibrosis",2,0.02248,"1.00e+00",-0.01818,"1.00e+00",0.00429,"1.00e+00"
"Hedgehog ligand biogenesis",2,0.02248,"1.00e+00",-0.01818,"1.00e+00",0.00429,"1.00e+00"
"Hh mutants abrogate ligand secretion",2,0.02248,"1.00e+00",-0.01818,"1.00e+00",0.00429,"1.00e+00"
"Hh mutants are degraded by ERAD",2,0.02248,"1.00e+00",-0.01818,"1.00e+00",0.00429,"1.00e+00"
"Neddylation",2,0.02248,"1.00e+00",-0.01818,"1.00e+00",0.00429,"1.00e+00"
"Arachidonic acid metabolism",2,0.02236,"1.00e+00",0.00463,"1.00e+00",-0.01774,"1.00e+00"
"Transport of bile salts and organic acids, metal ions and amine compounds",5,0.02216,"1.00e+00",-0.02001,"1.00e+00",0.00214,"1.00e+00"
"Hedgehog 'off' state",2,0.02189,"1.00e+00",0.00053,"1.00e+00",-0.02136,"1.00e+00"
"Cellular response to chemical stress",15,0.02171,"1.00e+00",0.00523,"1.00e+00",-0.01648,"1.00e+00"
"Glyoxylate metabolism and glycine degradation",15,0.02156,"1.00e+00",-0.02005,"1.00e+00",0.00151,"1.00e+00"
"Pregnenolone biosynthesis",2,0.02082,"1.00e+00",0.01813,"1.00e+00",-0.00269,"1.00e+00"
"tRNA Aminoacylation",10,0.02081,"1.00e+00",-0.00705,"1.00e+00",0.01376,"1.00e+00"
"Cellular response to starvation",9,0.02069,"1.00e+00",-0.01665,"1.00e+00",0.00404,"1.00e+00"
"Response of EIF2AK4 (GCN2) to amino acid deficiency",9,0.02069,"1.00e+00",-0.01665,"1.00e+00",0.00404,"1.00e+00"
"Base-Excision Repair, AP Site Formation",6,0.02047,"1.00e+00",-0.01736,"1.00e+00",0.00311,"1.00e+00"
"Translation",52,0.02017,"1.00e+00",-0.01344,"1.00e+00",0.00674,"1.00e+00"
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",6,0.02015,"1.00e+00",0.00652,"1.00e+00",-0.01363,"1.00e+00"
"Ribosomal scanning and start codon recognition",6,0.02015,"1.00e+00",0.00652,"1.00e+00",-0.01363,"1.00e+00"
"Translation initiation complex formation",6,0.02015,"1.00e+00",0.00652,"1.00e+00",-0.01363,"1.00e+00"
"Methylation",5,0.01919,"1.00e+00",0.00403,"1.00e+00",-0.01516,"1.00e+00"
"Insulin processing",2,0.01919,"1.00e+00",-0.04695,"1.00e+00",-0.00858,"1.00e+00"
"Ribavirin ADME",3,0.01917,"1.00e+00",0.00567,"1.00e+00",-0.0135,"1.00e+00"
"Choline catabolism",2,0.01911,"1.00e+00",0.01131,"1.00e+00",-0.0078,"1.00e+00"
"KEAP1-NFE2L2 pathway",10,0.0182,"1.00e+00",0.00157,"1.00e+00",-0.01662,"1.00e+00"
"Post-translational protein modification",26,0.01819,"1.00e+00",0.00135,"1.00e+00",-0.01684,"1.00e+00"
"Diseases of nucleotide metabolism",4,0.01794,"1.00e+00",0.01443,"1.00e+00",-0.00351,"1.00e+00"
"Purine salvage",4,0.01794,"1.00e+00",0.01443,"1.00e+00",-0.00351,"1.00e+00"
"Late SARS-CoV-2 Infection Events",2,0.01736,"1.00e+00",-0.0078,"1.00e+00",0.00957,"1.00e+00"
"Maturation of nucleoprotein_9683610",2,0.01736,"1.00e+00",-0.0078,"1.00e+00",0.00957,"1.00e+00"
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",2,0.01434,"9.80e-01",0.00898,"1.00e+00",0.03766,"9.80e-01"
"Paracetamol ADME",4,0.01316,"6.45e-01",-0.04152,"6.45e-01",-0.0152,"1.00e+00"
"Maturation of nucleoprotein_9694631",2,0.01736,"1.00e+00",-0.0078,"1.00e+00",0.00957,"1.00e+00"
"Translation of Structural Proteins_9683701",2,0.01736,"1.00e+00",-0.0078,"1.00e+00",0.00957,"1.00e+00"
"Translation of Structural Proteins_9694635",2,0.01736,"1.00e+00",-0.0078,"1.00e+00",0.00957,"1.00e+00"
"Eukaryotic Translation Termination",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Formation of a pool of free 40S subunits",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Nonsense-Mediated Decay (NMD)",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Selenocysteine synthesis",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Viral mRNA Translation",8,0.01706,"1.00e+00",-0.01414,"1.00e+00",0.00292,"1.00e+00"
"Diseases associated with N-glycosylation of proteins",2,0.01681,"1.00e+00",0.00214,"1.00e+00",-0.01467,"1.00e+00"
"Cell Cycle Checkpoints",2,0.01652,"1.00e+00",-0.0106,"1.00e+00",0.00592,"1.00e+00"
"G2/M Checkpoints",2,0.01652,"1.00e+00",-0.0106,"1.00e+00",0.00592,"1.00e+00"
"Autophagy",3,0.01649,"1.00e+00",-0.03551,"1.00e+00",-0.00252,"1.00e+00"
"Cellular response to heat stress",3,0.01649,"1.00e+00",-0.03551,"1.00e+00",-0.00252,"1.00e+00"
"HSF1 activation",3,0.01649,"1.00e+00",-0.03551,"1.00e+00",-0.00252,"1.00e+00"
"Mitochondrial tRNA aminoacylation",9,0.01647,"1.00e+00",-0.00729,"1.00e+00",0.00917,"1.00e+00"
"Metabolism of carbohydrates",31,0.01643,"1.00e+00",0.00678,"1.00e+00",-0.00965,"1.00e+00"
"SARS-CoV-1 Infection",10,0.01634,"1.00e+00",-0.01457,"1.00e+00",0.00177,"1.00e+00"
"tRNA processing",11,0.01617,"1.00e+00",-0.00745,"1.00e+00",0.00872,"1.00e+00"
"Asparagine N-linked glycosylation",12,0.01612,"1.00e+00",0.00295,"1.00e+00",-0.01317,"1.00e+00"
"NFE2L2 regulating TCA cycle genes",2,0.01602,"1.00e+00",-0.01331,"1.00e+00",-0.04536,"1.00e+00"
"Glycine degradation",4,0.01602,"1.00e+00",0.00797,"1.00e+00",-0.00805,"1.00e+00"
"Innate Immune System",35,0.01593,"1.00e+00",-0.01579,"1.00e+00",0.00014,"1.00e+00"
"rRNA processing in the nucleus and cytosol",13,0.01592,"1.00e+00",-0.01507,"1.00e+00",0.00084,"1.00e+00"
"M Phase",3,0.0159,"1.00e+00",0.00154,"1.00e+00",-0.01436,"1.00e+00"
"Metabolism of folate and pterines",5,0.01586,"1.00e+00",-0.00416,"1.00e+00",0.0117,"1.00e+00"
"Developmental Biology",17,0.01584,"1.00e+00",-0.01064,"1.00e+00",0.00519,"1.00e+00"
"mRNA Splicing - Major Pathway",5,0.0157,"1.00e+00",-0.00496,"1.00e+00",0.01074,"1.00e+00"
"mRNA Splicing",5,0.0157,"1.00e+00",-0.00496,"1.00e+00",0.01074,"1.00e+00"
"Processing of Capped Intron-Containing Pre-mRNA",5,0.0157,"1.00e+00",-0.00496,"1.00e+00",0.01074,"1.00e+00"
"Resolution of Abasic Sites (AP sites)",8,0.0156,"1.00e+00",-0.01186,"1.00e+00",0.00374,"1.00e+00"
"Metabolism of polyamines",3,0.01468,"1.00e+00",0.00924,"1.00e+00",-0.00544,"1.00e+00"
"TYSND1 cleaves peroxisomal proteins",4,0.01421,"1.00e+00",0.01284,"1.00e+00",-0.00138,"1.00e+00"
"Base Excision Repair",9,0.01421,"1.00e+00",-0.01299,"1.00e+00",0.00122,"1.00e+00"
"Nicotinate metabolism",6,0.01389,"1.00e+00",-0.00653,"1.00e+00",0.00736,"1.00e+00"
"Abacavir ADME",3,0.01375,"1.00e+00",-0.0061,"1.00e+00",-0.0336,"1.00e+00"
"Major pathway of rRNA processing in the nucleolus and cytosol",12,0.01337,"1.00e+00",-0.01326,"1.00e+00",0.00012,"1.00e+00"
"Regulation of pyruvate dehydrogenase (PDH) complex",2,0.01323,"1.00e+00",-0.00726,"1.00e+00",0.00598,"1.00e+00"
"Diseases associated with glycosylation precursor biosynthesis",6,0.01318,"1.00e+00",0.00663,"1.00e+00",-0.00656,"1.00e+00"
"SRP-dependent cotranslational protein targeting to membrane",9,0.01296,"1.00e+00",-0.01032,"1.00e+00",0.00264,"1.00e+00"
"Axon guidance",10,0.01274,"1.00e+00",-0.01124,"1.00e+00",0.0015,"1.00e+00"
"Metabolism",281,0.01252,"1.00e+00",0.00433,"1.00e+00",-0.00819,"1.00e+00"
"Interconversion of nucleotide di- and triphosphates",12,0.01246,"1.00e+00",-0.00628,"1.00e+00",0.00618,"1.00e+00"
"Diseases of metabolism",34,0.01221,"1.00e+00",0.00417,"1.00e+00",-0.00804,"1.00e+00"
"Selenoamino acid metabolism",13,0.01134,"1.00e+00",-0.00985,"1.00e+00",0.00148,"1.00e+00"
"Metabolism of nucleotides",36,0.01088,"1.00e+00",-0.0028,"1.00e+00",0.00808,"1.00e+00"
"Beta oxidation of butanoyl-CoA to acetyl-CoA",3,0.01084,"1.00e+00",0.00529,"1.00e+00",-0.00555,"1.00e+00"
"G1/S-Specific Transcription",2,0.01066,"1.00e+00",0.01264,"1.00e+00",0.03396,"1.00e+00"
"Synthesis of GDP-mannose",2,0.01059,"1.00e+00",0.00464,"1.00e+00",-0.00595,"1.00e+00"
"Metabolic disorders of biological oxidation enzymes",6,0.01052,"1.00e+00",-0.00919,"1.00e+00",0.00134,"1.00e+00"
"Metabolism of RNA",33,0.01039,"1.00e+00",-0.00622,"1.00e+00",0.00417,"1.00e+00"
"Multifunctional anion exchangers",2,0.01034,"1.00e+00",0.00834,"1.00e+00",-0.002,"1.00e+00"
"Diseases associated with O-glycosylation of proteins",2,0.0103,"1.00e+00",-0.00829,"1.00e+00",0.002,"1.00e+00"
"O-linked glycosylation",2,0.0103,"1.00e+00",-0.00829,"1.00e+00",0.002,"1.00e+00"
"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",2,0.00995,"1.00e+00",-0.00522,"1.00e+00",-0.02512,"1.00e+00"
"The activation of arylsulfatases",2,0.00995,"1.00e+00",-0.00522,"1.00e+00",-0.02512,"1.00e+00"
"Beta-oxidation of very long chain fatty acids",4,0.00993,"1.00e+00",0.00247,"1.00e+00",-0.00746,"1.00e+00"
"Glycolysis",9,0.00989,"1.00e+00",0.00299,"1.00e+00",-0.0069,"1.00e+00"
"mRNA Splicing - Minor Pathway",3,0.00978,"1.00e+00",0.00593,"1.00e+00",-0.00385,"1.00e+00"
"Mitochondrial biogenesis",6,0.00977,"1.00e+00",0.00076,"1.00e+00",-0.00901,"1.00e+00"
"Transcriptional activation of mitochondrial biogenesis",6,0.00977,"1.00e+00",0.00076,"1.00e+00",-0.00901,"1.00e+00"
"Diseases of glycosylation",10,0.00921,"1.00e+00",0.00275,"1.00e+00",-0.00647,"1.00e+00"
"tRNA modification in the nucleus and cytosol",6,0.00884,"1.00e+00",-0.00712,"1.00e+00",0.00172,"1.00e+00"
"PIP3 activates AKT signaling",2,0.00871,"1.00e+00",-0.0078,"1.00e+00",9e-04,"1.00e+00"
"Respiratory electron transport",16,0.00867,"1.00e+00",0.00739,"1.00e+00",-0.00128,"1.00e+00"
"Pyrimidine biosynthesis",3,0.00854,"1.00e+00",-0.00557,"1.00e+00",0.00297,"1.00e+00"
"FOXO-mediated transcription",4,0.00816,"1.00e+00",-0.00122,"1.00e+00",0.00694,"1.00e+00"
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",3,0.00774,"1.00e+00",0.00478,"1.00e+00",-0.00296,"1.00e+00"
"Formation of the ternary complex, and subsequently, the 43S complex",5,0.00768,"1.00e+00",0.00079,"1.00e+00",-0.0069,"1.00e+00"
"SARS-CoV-2 modulates host translation machinery",5,0.00768,"1.00e+00",0.00079,"1.00e+00",-0.0069,"1.00e+00"
"Metabolism of amino acids and derivatives",71,0.00732,"1.00e+00",0.00239,"1.00e+00",-0.00493,"1.00e+00"
"Signaling by Hedgehog",3,0.0073,"1.00e+00",-0.01798,"1.00e+00",-0.00338,"1.00e+00"
"Ethanol oxidation",3,0.00728,"1.00e+00",-0.00711,"1.00e+00",0.00017,"1.00e+00"
"Synthesis of Ketone Bodies",2,0.00706,"1.00e+00",-0.00594,"1.00e+00",-0.02006,"1.00e+00"
"Glycerophospholipid catabolism",2,0.00701,"1.00e+00",-0.01631,"1.00e+00",-0.03034,"1.00e+00"
"PI Metabolism",2,0.00701,"1.00e+00",-0.01631,"1.00e+00",-0.03034,"1.00e+00"
"TP53 Regulates Metabolic Genes",8,0.00701,"1.00e+00",-0.01411,"1.00e+00",-1e-04,"1.00e+00"
"Cleavage of the damaged pyrimidine",4,0.00672,"1.00e+00",-0.01429,"1.00e+00",-0.00085,"1.00e+00"
"Depyrimidination",4,0.00672,"1.00e+00",-0.01429,"1.00e+00",-0.00085,"1.00e+00"
"Recognition and association of DNA glycosylase with site containing an affected pyrimidine",4,0.00672,"1.00e+00",-0.01429,"1.00e+00",-0.00085,"1.00e+00"
"SARS-CoV Infections",14,0.00669,"1.00e+00",-0.01436,"1.00e+00",-0.00099,"1.00e+00"
"Phase II - Conjugation of compounds",12,0.00666,"1.00e+00",-0.00971,"1.00e+00",-0.02303,"1.00e+00"
"The citric acid (TCA) cycle and respiratory electron transport",32,0.00653,"1.00e+00",0.00089,"1.00e+00",-0.00564,"1.00e+00"
"Pyruvate metabolism and Citric Acid (TCA) cycle",17,0.00644,"1.00e+00",-0.00226,"1.00e+00",-0.01515,"1.00e+00"
"Eukaryotic Translation Elongation",9,0.00635,"1.00e+00",-0.01631,"1.00e+00",-0.0036,"1.00e+00"
"Peptide chain elongation",9,0.00635,"1.00e+00",-0.01631,"1.00e+00",-0.0036,"1.00e+00"
"Metabolism of water-soluble vitamins and cofactors",33,0.00529,"1.00e+00",0.00422,"1.00e+00",-0.00107,"1.00e+00"
"ABC-family proteins mediated transport",9,0.00527,"1.00e+00",-0.00401,"1.00e+00",-0.01454,"1.00e+00"
"Regulation of expression of SLITs and ROBOs",9,0.00521,"1.00e+00",-0.0105,"1.00e+00",-7e-05,"1.00e+00"
"Signaling by ROBO receptors",9,0.00521,"1.00e+00",-0.0105,"1.00e+00",-7e-05,"1.00e+00"
"Cell Cycle, Mitotic",8,0.0051,"1.00e+00",-0.00143,"1.00e+00",0.00367,"1.00e+00"
"DNA Replication",3,0.00505,"1.00e+00",-0.00159,"1.00e+00",-0.01169,"1.00e+00"
"S Phase",3,0.00505,"1.00e+00",-0.00159,"1.00e+00",-0.01169,"1.00e+00"
"Synthesis of DNA",3,0.00505,"1.00e+00",-0.00159,"1.00e+00",-0.01169,"1.00e+00"
"SARS-CoV-1 modulates host translation machinery",6,0.00505,"1.00e+00",-0.00494,"1.00e+00",-0.01504,"1.00e+00"
"RHOG GTPase cycle",3,0.00501,"1.00e+00",0.01418,"1.00e+00",0.00416,"1.00e+00"
"Peptide hormone metabolism",4,0.0049,"1.00e+00",-0.00934,"1.00e+00",-0.01913,"1.00e+00"
"The role of GTSE1 in G2/M progression after G2 checkpoint",2,0.00454,"1.00e+00",0.00036,"1.00e+00",-0.00418,"1.00e+00"
"Mitochondrial RNA degradation",2,0.00453,"1.00e+00",0.02587,"1.00e+00",0.01682,"1.00e+00"
"Organelle biogenesis and maintenance",7,0.00453,"1.00e+00",-0.00159,"1.00e+00",-0.01064,"1.00e+00"
"Iron uptake and transport",4,0.0045,"1.00e+00",0.00055,"1.00e+00",-0.00396,"1.00e+00"
"Cobalamin (Cbl, vitamin B12) transport and metabolism",4,0.00444,"1.00e+00",-0.00695,"1.00e+00",-0.01584,"1.00e+00"
"Defects in cobalamin (B12) metabolism",4,0.00444,"1.00e+00",-0.00695,"1.00e+00",-0.01584,"1.00e+00"
"Bacterial Infection Pathways",2,0.00426,"1.00e+00",0.00931,"1.00e+00",0.00079,"1.00e+00"
"Generic Transcription Pathway",18,0.0041,"1.00e+00",-0.00843,"1.00e+00",-0.00023,"1.00e+00"
"RNA Polymerase II Transcription",18,0.0041,"1.00e+00",-0.00843,"1.00e+00",-0.00023,"1.00e+00"
"Metabolism of vitamins and cofactors",40,0.00384,"1.00e+00",0.00364,"1.00e+00",-2e-04,"1.00e+00"
"Glycogen metabolism",3,0.00381,"1.00e+00",-0.01025,"1.00e+00",-0.00263,"1.00e+00"
"SARS-CoV-2 Infection",11,0.00379,"1.00e+00",-0.00887,"1.00e+00",-0.00128,"1.00e+00"
"Nucleotide catabolism",6,0.00371,"1.00e+00",9e-05,"1.00e+00",0.00751,"1.00e+00"
"Glucose metabolism",13,0.00367,"1.00e+00",-0.00126,"1.00e+00",0.00241,"1.00e+00"
"Post-translational protein phosphorylation",2,0.0036,"1.00e+00",-0.02571,"1.00e+00",-0.01851,"1.00e+00"
"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",2,0.0036,"1.00e+00",-0.02571,"1.00e+00",-0.01851,"1.00e+00"
"Purine catabolism",4,0.00355,"1.00e+00",0.01394,"1.00e+00",0.00684,"1.00e+00"
"DNA strand elongation",2,0.00308,"1.00e+00",-0.01171,"1.00e+00",-0.00555,"1.00e+00"
"Extension of Telomeres",2,0.00308,"1.00e+00",-0.01171,"1.00e+00",-0.00555,"1.00e+00"
"Lagging Strand Synthesis",2,0.00308,"1.00e+00",-0.01171,"1.00e+00",-0.00555,"1.00e+00"
"Telomere C-strand (Lagging Strand) Synthesis",2,0.00308,"1.00e+00",-0.01171,"1.00e+00",-0.00555,"1.00e+00"
"Cap-dependent Translation Initiation",9,0.003,"1.00e+00",-0.00867,"1.00e+00",-0.00266,"1.00e+00"
"Eukaryotic Translation Initiation",9,0.003,"1.00e+00",-0.00867,"1.00e+00",-0.00266,"1.00e+00"
"GTP hydrolysis and joining of the 60S ribosomal subunit",9,0.003,"1.00e+00",-0.00867,"1.00e+00",-0.00266,"1.00e+00"
"L13a-mediated translational silencing of Ceruloplasmin expression",9,0.003,"1.00e+00",-0.00867,"1.00e+00",-0.00266,"1.00e+00"
"Signal Transduction",28,0.00297,"1.00e+00",-2e-05,"1.00e+00",-0.00595,"1.00e+00"
"Nucleotide salvage defects",3,0.00296,"1.00e+00",0.00434,"1.00e+00",0.01026,"1.00e+00"
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",17,0.00289,"1.00e+00",0.00645,"1.00e+00",0.00066,"1.00e+00"
"Chaperone Mediated Autophagy",2,0.00285,"1.00e+00",-0.02576,"1.00e+00",-0.02007,"1.00e+00"
"Nicotinamide salvaging",3,0.00282,"1.00e+00",-0.01182,"1.00e+00",-0.00619,"1.00e+00"
"Pyruvate metabolism",5,0.00281,"1.00e+00",-0.00064,"1.00e+00",-0.00625,"1.00e+00"
"Metabolism of proteins",112,0.00272,"1.00e+00",-0.00167,"1.00e+00",-0.00712,"1.00e+00"
"Intracellular signaling by second messengers",3,0.00271,"1.00e+00",-0.01106,"1.00e+00",-0.00564,"1.00e+00"
"Glutamate and glutamine metabolism",3,0.00269,"1.00e+00",0.0165,"1.00e+00",0.01111,"1.00e+00"
"SARS-CoV-2-host interactions",8,0.00243,"1.00e+00",-0.00338,"1.00e+00",-0.00823,"1.00e+00"
"Beta-oxidation of pristanoyl-CoA",4,0.00233,"1.00e+00",-0.00885,"1.00e+00",-0.00419,"1.00e+00"
"Deubiquitination",3,0.00233,"1.00e+00",-0.00328,"1.00e+00",-0.00793,"1.00e+00"
"ABC transporters in lipid homeostasis",3,0.00232,"1.00e+00",0.00335,"1.00e+00",0.00799,"1.00e+00"
"G2/M Transition",3,0.0023,"1.00e+00",-0.00499,"1.00e+00",-0.00959,"1.00e+00"
"Mitotic G2-G2/M phases",3,0.0023,"1.00e+00",-0.00499,"1.00e+00",-0.00959,"1.00e+00"
"Neutrophil degranulation",31,0.00216,"1.00e+00",-0.01032,"1.00e+00",-0.00599,"1.00e+00"
"Gene expression (Transcription)",20,0.00196,"1.00e+00",-0.0051,"1.00e+00",-0.00117,"1.00e+00"
"Adaptive Immune System",2,0.00187,"1.00e+00",0.02244,"1.00e+00",0.01869,"1.00e+00"
"Defects in vitamin and cofactor metabolism",8,0.00184,"1.00e+00",-0.0014,"1.00e+00",-0.00509,"1.00e+00"
"Glycosphingolipid catabolism",4,0.00181,"1.00e+00",-0.01818,"1.00e+00",-0.01456,"1.00e+00"
"Mitotic Prometaphase",2,0.00127,"1.00e+00",-0.00701,"1.00e+00",-0.00955,"1.00e+00"
"RA biosynthesis pathway",5,0.00123,"1.00e+00",-0.01507,"1.00e+00",-0.01753,"1.00e+00"
"SARS-CoV-1-host interactions",8,0.00122,"1.00e+00",-0.00595,"1.00e+00",-0.00839,"1.00e+00"
"Cellular responses to stimuli",29,0.00121,"1.00e+00",-0.00776,"1.00e+00",-0.00534,"1.00e+00"
"Cellular responses to stress",29,0.00121,"1.00e+00",-0.00776,"1.00e+00",-0.00534,"1.00e+00"
"Threonine catabolism",2,0.00121,"1.00e+00",-0.00474,"1.00e+00",-0.00716,"1.00e+00"
"Branched-chain amino acid catabolism",13,0.00111,"1.00e+00",-0.00436,"1.00e+00",-0.00214,"1.00e+00"
"Disease",79,0.00109,"1.00e+00",-0.0019,"1.00e+00",-0.00409,"1.00e+00"
"Nervous system development",11,0.00109,"1.00e+00",-0.00538,"1.00e+00",-0.00319,"1.00e+00"
"Signaling by Retinoic Acid",7,0.00101,"1.00e+00",-0.01284,"1.00e+00",-0.01081,"1.00e+00"
"Defective Intrinsic Pathway for Apoptosis",2,0.00098,"1.00e+00",-0.00042,"1.00e+00",0.00056,"1.00e+00"
"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",2,0.00098,"1.00e+00",-0.00042,"1.00e+00",0.00056,"1.00e+00"
"Diseases of programmed cell death",2,0.00098,"1.00e+00",-0.00042,"1.00e+00",0.00056,"1.00e+00"
"Neurodegenerative Diseases",2,0.00098,"1.00e+00",-0.00042,"1.00e+00",0.00056,"1.00e+00"
"Aflatoxin activation and detoxification",2,0.00097,"1.00e+00",-0.02022,"1.00e+00",-0.01828,"1.00e+00"
"PCNA-Dependent Long Patch Base Excision Repair",3,0.00085,"1.00e+00",-0.00424,"1.00e+00",-0.00255,"1.00e+00"
"Resolution of AP sites via the multiple-nucleotide patch replacement pathway",3,0.00085,"1.00e+00",-0.00424,"1.00e+00",-0.00255,"1.00e+00"
"Pentose phosphate pathway",8,0.00083,"1.00e+00",-0.00341,"1.00e+00",-0.00507,"1.00e+00"
"Biotin transport and metabolism",4,0.00076,"1.00e+00",0.00415,"1.00e+00",0.00566,"1.00e+00"
"Defective HLCS causes multiple carboxylase deficiency",4,0.00076,"1.00e+00",0.00415,"1.00e+00",0.00566,"1.00e+00"
"Defects in biotin (Btn) metabolism",4,0.00076,"1.00e+00",0.00415,"1.00e+00",0.00566,"1.00e+00"
"Triglyceride metabolism",4,0.00065,"1.00e+00",0.00419,"1.00e+00",0.00288,"1.00e+00"
"Gluconeogenesis",10,6e-04,"1.00e+00",0.00106,"1.00e+00",0.00226,"1.00e+00"
"Immune System",42,0.00043,"1.00e+00",-0.00681,"1.00e+00",-0.00595,"1.00e+00"
"tRNA modification in the mitochondrion",5,0.00041,"1.00e+00",0.0065,"1.00e+00",0.00569,"1.00e+00"
"Drug ADME",17,0.00029,"1.00e+00",-0.00784,"1.00e+00",-0.00726,"1.00e+00"
"Lysine catabolism",6,0.00021,"1.00e+00",-0.00193,"1.00e+00",-0.00236,"1.00e+00"
"NFE2L2 regulating anti-oxidant/detoxification enzymes",3,0.00016,"1.00e+00",0.00574,"1.00e+00",0.00541,"1.00e+00"
"G1/S Transition",3,0,"1.00e+00",0.01464,"1.00e+00",0.01464,"1.00e+00"
"Mitotic G1 phase and G1/S transition",3,0,"1.00e+00",0.01464,"1.00e+00",0.01464,"1.00e+00"
